Table 5.

Association of RAS inhibitor use with brain infarcts.

RAS inhibitor use	OR, Estimate (SE, p‐value)
	Any infarct	Size of infarct		Location of infarct
		Gross infarcts	Micro‐infarcts	Cortical infarcts	Subcortical infarcts
During the study	1.294, 0.258 (0.353, 0.465)	1.315, 0.274 (0.367, 0.457)	1.584, 0.460 (0.392, 0.240)	1.480, 0.392 (0.424, 0.356)	1.480, 0.392 (0.372, 0.292)
During last 5 years of life	1.812, 0.594 (0.344, 0.084)	1.564, 0.447 (0.356, 0.209)	2.579, 0.947 (0.385, 0.014)	2.2436, 0.808 (0.418, 0.053)	1.805, 0.591 (0.360, 0.101)

Each linear regression model with individual measure of brain infarcts as the outcome has been adjusted for age at death, sex, and diabetes. Bold values denote statistical significance (p < 0.05).